Antiretroviral Therapy and the Lipodystrophy Syndrome-Reference-Cited by-同舟云学术

Antiretroviral Therapy and the Lipodystrophy Syndrome

Published:2001-01 Issue:1 Volume:6 Page:9-20
ISSN:1359-6535
Container-title:Antiviral Therapy
language:en
Short-container-title:Antiviral Therapy

Author:

John Mina¹,Nolan David¹,Mallal Simon¹

Affiliation:

1. Centre for Clinical Immunology and Biomedical Statistics, Royal Perth Hospital and Murdoch University, Western Australia, Australia

Abstract

‘Lipodystrophy syndrome’ in the setting of HIV infection has come to encompass a collection of morphological and metabolic abnormalities linked with the use of antiretroviral therapy and other risk factors. We review the clinical literature on this subject as it has evolved historically, taking pertinent methodological issues into account.

Publisher

SAGE Publications

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

http://journals.sagepub.com/doi/pdf/10.1177/135965350100600102

Reference131 articles.

1. Indinavir-associated lipodystrophy

2. Benign symmetric lipomatosis associated with protease inhibitors

3. Hypertrophy of the Breasts in a Patient Treated with Indinavir

4. Another Case of Breast Hypertrophy in a Patient Treated with Indinavir

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inflammation in HIV and Its Impact on Atherosclerotic Cardiovascular Disease;Circulation Research;2024-05-24

2. The Problems Faced When Assessing the Prevalence and Incidence of Antiretroviral-Related Toxicities;Antiviral Therapy;2004-08

3. Complications Associated with Nrti Therapy: Update on Clinical Features and Possible Pathogenic Mechanisms;Antiviral Therapy;2004-08

4. Lipodystrophy in Patients with HIV-1 Infection: Effect of Stopping Protease Inhibitors on Tnf-α and Tnf-Receptor Levels, and on Metabolic Parameters;Antiviral Therapy;2004-08

5. Adipocytes Targets and Actors in the Pathogenesis of HIV-Associated Lipodystrophy and Metabolic Alterations;Antiviral Therapy;2004-02